Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Common Equity (2020 - 2026)

Bioventus filings provide 6 years of Common Equity readings, the most recent being $228.4 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 54.42% to $228.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $228.4 million, a 54.42% increase, with the full-year FY2025 number at $228.4 million, up 54.42% from a year prior.
  • Common Equity hit $228.4 million in Q4 2025 for Bioventus, up from $166.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $607.7 million in Q4 2021 to a low of $147.9 million in Q4 2024.
  • Median Common Equity over the past 5 years was $223.8 million (2023), compared with a mean of $288.5 million.
  • Biggest five-year swings in Common Equity: surged 321.51% in 2021 and later tumbled 60.59% in 2023.
  • Bioventus' Common Equity stood at $607.7 million in 2021, then tumbled by 32.16% to $412.2 million in 2022, then crashed by 46.36% to $221.1 million in 2023, then plummeted by 33.09% to $147.9 million in 2024, then skyrocketed by 54.42% to $228.4 million in 2025.
  • The last three reported values for Common Equity were $228.4 million (Q4 2025), $166.1 million (Q3 2025), and $201.3 million (Q2 2025) per Business Quant data.